The awards were made under the Health Research Board’s (HRB’s) Conference and Events Sponsorship (CES) Scheme, which is designed to facilitate enhanced visibility, reach and pathways to impact for health research. They have a combined value of approximately €100,000.

The awards span a multitude of disease areas and topics across the entire research spectrum, from laboratory-based molecular medicine and genomics research to patient-facing primary care and community care initiatives. They support a wide range of activities that connect research teams with other researchers, with patients and carers, the general public, healthcare professionals, policy makers and other knowledge users.

Dr Mairéad O’Driscoll, Chief Executive at the HRB, said:

“The HRB’s CES Scheme serves a number of important functions. It promotes the impact of health research, data and evidence for patient care, health service delivery and health policy. It creates opportunities for strategic national and international collaboration and it helps to communicate the impact of HRB-funded work.”



The awards will facilitate conferences and events on topics including digital surgery, digital mental health interventions, dementia and stroke care, adult safeguarding, and tapering strategies for psychiatric medicine. A full list of the events is available below.

Dr Aoife Cahill, Programme Manager: Investigator-led grants and PPI at the HRB, said:

“This year’s CES scheme was especially pleasing because it included so many applications which involve the public, patients and carers. This aligns with our promotion of PPI and our strategic commitment of ensuring that people remain at the heart of everything that we do.

“The supported activities can focus on sharing of findings, on discussing research methodologies, on debating future research and evidence needs, on informing policy planning or implementation or on fostering greater (national or international) research collaboration.

“Also notable was the fact that the scheme is attracting applications from beyond our usual host institutions, as it is open to all health-related organisations with a focus on research.  We hope that these trends will continue when the next round of the scheme opens in early 2024.”